ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$6.70
Tradestie Score
61
Market Cap
$1.78B
Revenue Growth
1.0%
Analyst Upside
+56.7%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$133.74
|
$2.35B | - | 57 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.81
|
$2.34B | - | 57 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$74.81
|
$2.33B | - | 63 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$40.38
|
$2.33B | - | 57 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.43
|
$2.23B | - | 58 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.23
|
$2.22B | - | 60 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$55.91
|
$2.21B | - | 63 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$26.14
|
$2.18B | - | 63 | Compare |
|
CERT
Certara, Inc. Common Stock
|
$6.96
|
$2.15B | - | 60 | Compare |
More ABCL Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry